top of page

Updating the latest information on studies, developments,
and events related to Therabiopharma Inc.


Press Release: CMG and Oxaliplatin studies for colon cancer
Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong...
Jul 26, 2021


GAP 2018 Conference (Karolinska Institute in Sweden)
Our recent progress on a water-soluble curcumin monoglucronide (CMG) will be presented at the GAP (Global Academic Programs) conference...
Jul 26, 2021


Press release from the Kyoto University
The Kyoto university released a academic paper showing the pharmacokinetics and anticancer effects of highly safe water-soluble prodrug...
Sep 1, 2017


New research base, new address.
Our research base of THERABIOPHARMA is newly established in the Innovation Center East 604 inside the Kanagawa Science Park.
Aug 14, 2017


Our investigation results received media exposure
As collaborative research results with Kyoto University,Professor Masafumi Kanai (Graduate School of Medicine, Kyoto University )...
Jul 17, 2017
bottom of page
